However, despite the insufficient understanding of the etiology of this group of heterogeneous diseases, German hematologists have solved many problems in the treatment of hematological pathology.
In this European country, there are government programs dedicated to studying topical issues in hematology. Hematology centers, research institutes, and specialized departments of multidisciplinary clinics jointly create and implement innovative treatment methods into practice. Treatment of hemoblastosis in Germany is carried out by doctors of science with worldwide reputations, and professors from the Department of Hematology of the Medical Center "Rhein-Ruhr" also participate in consolidated scientific work.
Our clinic uses the most modern pharmacological agents for cytostatic therapy. Highly effective drugs that were only yesterday undergoing phase III clinical trials are already being prescribed to patients of the Medical Center "Rhein-Ruhr" today, which allows increasing the effectiveness of chemoradiotherapy and achieving the transition of hematological pathology to a stage of true clinical remission.
The therapeutic process is significantly complicated by the lack of hematological response to many antitumor agents (due to insensitivity of malignant cells to chemotherapy). However, for our doctors this is not a problem. Thanks to the introduction of the latest targeted therapy agents, the hematologists of the "Rhein-Ruhr" clinic successfully cope with the phenomenon of multiple drug resistance and restore to a full life patients for whom standard treatment protocols did not help.
The drugs used today in the drug treatment of lymphocytoma in Germany, in the protocols of chemoradiotherapy for hematosarcoma and leukemia, have passed all stages of clinical trials. It has already been proven that the inclusion of the latest generation targeted drugs in the algorithms of cytostatic therapy for leukemia promotes rapid resolution of blast crisis with subsequent transition of the disease to a stage of stable remission, which dramatically increases the chances for successful transplantation of hematopoietic organs.
At the hospital stage, the prevention of complications and side effects of chemoradiotherapy is of great importance. Hematologists of "Rhein-Ruhr" help their patients successfully overcome this difficult stage of therapy. Thanks to the efforts of the attentive clinic staff, treatment at "Rhein-Ruhr" takes place in an atmosphere of kindness, home coziness and comfort. Our patients do not feel like sick people and do not encounter a language barrier. Entrust the treatment of hemoblastosis to true professionals, give yourself a new life!
PR